Percutaneous Coronary Intervention for Left Main Coronary Artery Disease: Present Status and Future Perspectives
Sangwoo Park1, Seung-Jung Park2, Duk-Woo Park2
1Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
Insights
Percutaneous coronary intervention (PCI) with drug-eluting stents is a safe alternative to coronary artery bypass grafting for left main coronary artery disease, especially in low-risk patients. Updated evidence is shaping future guidelines for LMCA revascularization strategies.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Coronary artery bypass grafting (CABG) has been the standard treatment for significant left main coronary artery (LMCA) disease.
- Advancements in percutaneous coronary intervention (PCI) technology and pharmacology offer an alternative approach.
Purpose of the Study:
- To review the evolution and current management strategies for LMCA disease.
- To evaluate PCI as a safe and effective alternative to CABG in select patients.
Main Methods:
- Review of landmark randomized clinical trials comparing PCI with CABG for LMCA disease.
- Analysis of long-term survival rates and patient outcomes based on anatomic risk.
Main Results:
- PCI with drug-eluting stents demonstrates similar long-term survival rates to CABG in patients with low and intermediate anatomic risk LMCA disease.
- PCI offers an expeditious approach with rapid recovery.
Conclusions:
- PCI is a safe and effective revascularization strategy for appropriately selected patients with LMCA disease.
- Ongoing research and updated trial evidence are crucial for refining future management guidelines.
Abstract:
For several decades, coronary artery bypass grafting has been regarded as the standard choice of revascularization for significant left main coronary artery (LMCA) disease. However, in conjunction with remarkable advancement of device technology and adjunctive pharmacology, percutaneous coronary intervention (PCI) offers a more expeditious approach with rapid recovery and is a safe and effective alternative in appropriately selected patients with LMCA disease. Several landmark randomized clinical trials showed that PCI with drug-eluting stents for LMCA disease is a safe option with similar long-term survival rates to coronary artery bypass grafting surgery, especially in those with low and intermediate anatomic risk. Although it is expected that the updated evidence from recent randomized clinical trials will determine the next guidelines for the foreseeable future, there are still unresolved and unmet issues of LMCA revascularization and PCI strategy. This paper provides a comprehensive review on the evolution and an update on the management of LMCA disease.
More Related Videos
05:48Left Coronary Artery Ligation: A Surgical Murine Model of Myocardial Infarction
Published on: August 9, 2022
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Cardiac Catheterization III: Left Heart Catheterization
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
